C07D215/10

Compound and dimer complex embodiments for supramolecular sensing

Disclosed herein are embodiments of a compound that can be used as a supramolecular sensor for determining the presence of analytes (e.g., illicit drugs), and for identifying and/or quantifying the analytes. Also disclosed herein is a parallel synthesis method for making compound embodiments, as well as method embodiments for using the compound embodiments. Array embodiments comprising one or more compound embodiments disclosed herein also are described.

Compound and dimer complex embodiments for supramolecular sensing

Disclosed herein are embodiments of a compound that can be used as a supramolecular sensor for determining the presence of analytes (e.g., illicit drugs), and for identifying and/or quantifying the analytes. Also disclosed herein is a parallel synthesis method for making compound embodiments, as well as method embodiments for using the compound embodiments. Array embodiments comprising one or more compound embodiments disclosed herein also are described.

QUINOLINE DERIVED SMALL MOLECULE INHIBITORS OF NICOTINAMIDE N-METHYLTRANSFERASE (NNMT) AND USES THEREOF

The present invention relates to quinoline derived small molecule inhibitors of nicotinamide N-methyltransferase (NNMT), the preparation thereof and uses thereof.

##STR00001##

QUINOLINE DERIVED SMALL MOLECULE INHIBITORS OF NICOTINAMIDE N-METHYLTRANSFERASE (NNMT) AND USES THEREOF

The present invention relates to quinoline derived small molecule inhibitors of nicotinamide N-methyltransferase (NNMT), the preparation thereof and uses thereof.

##STR00001##

CHARGED ION CHANNEL BLOCKERS AND METHODS FOR USE
20230107360 · 2023-04-06 ·

The invention provides compounds of Formula (I), or pharmaceutically acceptable salts 5 thereof:

##STR00001##

The compounds, compositions, methods and kits of the invention are useful for the treatment of pain, cough, itch, and neurogenic inflammation.

Charged ion channel blockers and methods for use

The invention provides compounds of Formula (I), or pharmaceutically acceptable salts thereof: ##STR00001##
The compounds, compositions, methods and kits of the invention are useful for the treatment of pain, cough, itch, and neurogenic inflammation.

Benzenesulfonyl-Asymmetric Ureas and Medical Uses Thereof
20170275301 · 2017-09-28 ·

Benzenesulfonyl-asymmetric ureas are provided for the treatment of conditions modulated by the ghrelin receptor.

Benzenesulfonyl-Asymmetric Ureas and Medical Uses Thereof
20170275301 · 2017-09-28 ·

Benzenesulfonyl-asymmetric ureas are provided for the treatment of conditions modulated by the ghrelin receptor.

FUNCTIONALIZED IONIC LIQUID FOR SOLVATING HEAVY AROMATIC COMPOUNDS
20230250061 · 2023-08-10 ·

A process for removing heavy polycyclic aromatic contaminants from a hydrocarbon stream using a quinolinium ionic liquid is described. The process includes contacting the hydrocarbon stream comprising the contaminant with a hydrocarbon-immiscible quinolinium ionic liquid to produce a mixture comprising the hydrocarbon and a hydrocarbon-immiscible quinolinium ionic liquid comprising at least a portion of the removed contaminant; and separating the mixture to produce a hydrocarbon effluent having a reduced level of the contaminant and a hydrocarbon-immiscible quinolinium ionic liquid effluent comprising the hydrocarbon-immiscible quinolinium ionic liquid comprising at least the portion of the removed contaminant.

FUNCTIONALIZED IONIC LIQUID FOR SOLVATING HEAVY AROMATIC COMPOUNDS
20230250061 · 2023-08-10 ·

A process for removing heavy polycyclic aromatic contaminants from a hydrocarbon stream using a quinolinium ionic liquid is described. The process includes contacting the hydrocarbon stream comprising the contaminant with a hydrocarbon-immiscible quinolinium ionic liquid to produce a mixture comprising the hydrocarbon and a hydrocarbon-immiscible quinolinium ionic liquid comprising at least a portion of the removed contaminant; and separating the mixture to produce a hydrocarbon effluent having a reduced level of the contaminant and a hydrocarbon-immiscible quinolinium ionic liquid effluent comprising the hydrocarbon-immiscible quinolinium ionic liquid comprising at least the portion of the removed contaminant.